Clinical trials · Chicago, IL
Multiple Sclerosis, Relapsing-Remitting clinical trials in Chicago
We’re tracking 6 recruiting multiple sclerosis, relapsing-remitting studies with a site in or near Chicago — including Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near Chicago
- NCT06390930Recruiting
Breathing bursts of lower oxygen for hand function in MS
This study tests whether breathing short bursts of reduced oxygen (acute intermittent hypoxia) can improve hand function and nerve health in people with relapsing-remitting MS who have some hand weakness.
Chicago, IllinoisAges 18–75 - NCT07225361RecruitingPhase 4
Ublituximab for early relapsing multiple sclerosis
This study tests ublituximab (Briumvi), a treatment given as an infusion, for people recently diagnosed with relapsing MS. The goal is to see if starting this treatment early helps control MS better.
Chicago, IllinoisAges 18–70 - NCT07355387Recruiting
Home-based balance training for multiple sclerosis
This study tests a 12-week home-based balance training program for people with multiple sclerosis. Sessions are done online with a helper present, and the goal is to improve walking and reduce fall risk.
Chicago, IllinoisAges 40–90 - NCT06276634Recruiting
Low-Oxygen Therapy for People With Multiple Sclerosis
This study tests whether brief, controlled low-oxygen episodes (called intermittent hypoxia) can improve motor function in people with MS. It may help strengthen walking and daily movement.
Chicago, IllinoisAges 18–75 - NCT06408259RecruitingPhase 3
Comparing ozanimod and fingolimod for children with MS
This study compares two oral medications, ozanimod and fingolimod, to see which one works better and is safer for children and teenagers with relapsing-remitting MS. Both drugs help reduce MS attacks and slow down the disease.
Chicago, IllinoisAges 10–17 - NCT06516458Recruiting
Camera-based gait study for people with MS
This study uses a camera to measure how you walk, called gait quality, to better understand movement in multiple sclerosis. It may help develop a simple way to track walking changes over time.
Chicago, IllinoisAges 18–75
Hear when a new Multiple Sclerosis, Relapsing-Remitting trial opens near Chicago, IL
We’ll email you when one opens near Chicago, IL — at most once a week, no account needed, unsubscribe anytime.
Multiple Sclerosis, Relapsing-Remitting trials in other cities
Where these studies are running near Chicago
Institutions with a site for the recruiting multiple sclerosis, relapsing-remitting studies listed above.
- Shirley Ryan AbilityLab · 3 studies
- Local Institution - 0093
- Northwestern Memorial Hospital
- University of Chicago
- University of Illinois
What taking part in a multiple sclerosis, relapsing-remitting study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting multiple sclerosis, relapsing-remitting studies in Illinois.
Common questions
- Are there multiple sclerosis, relapsing-remitting clinical trials near Chicago?
- Yes. We're currently tracking 6 recruiting multiple sclerosis, relapsing-remitting studies with a site near Chicago, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a multiple sclerosis, relapsing-remitting study near Chicago?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Chicago to take part?
- Not necessarily. These studies have a site near Chicago, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a multiple sclerosis, relapsing-remitting trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New multiple sclerosis, relapsing-remitting studies open near Chicago regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.